1. sayfa ve
Tekrarlanan kayıtlar tek bir kaynakta birleştirilmektedir.
1
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
COVID-19 in hypertensive people COVID-
19 is an infectious disease caused by the SARS-CoV-2 coronavirus that affects people in advanced ages of life, patients with immunodepression and With this work we wanted to update the knowledge on the
COVID-
19 serious condition level in hypertensive patients and its association with the consumption covid-19
2
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
COVID-19, hypertension, and cardiovascular disease for the cardiovascular (CV) health of patients, although the respiratory disease is the predominant clinical sign of
COVID-
19. Numerous patients with
COVID-
19 have basic CV ailments or develop severe heart injury due to the disease. Most of the current reports on
COVID-
19 have only briefly described CV manifestations in these patients. coronavirus disease-2019 (covid-19)
3
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
A proposal for staging COVID‐19 coagulopathy Abstract Coronavirus disease 2019 (
COVID‐
19) is associated with significant hypercoagulability. This forum discusses the lungs as the epicenter for the hemostatic issues, puts forward a proposal for staging
COVID‐
19 coagulopathy based on available COVID‐19
4
Dergi Makalesi

Dergi Makalesi

Kaynak
1:
Kaynak
2:
Dergi:
Yazar(lar) :
Yıl :
2020
COVID-19 Related Coagulopathy: A Distinct Entity? The coronavirus disease 2019 (
COVID-
19) pandemic has impacted healthcare communities across the globe on an unprecedented scale. Patients have had diverse clinical outcomes, but those developing
COVID-
19-related coagulopathy have shown a disproportionately worse outcome. -
19 coagulopathy. COVID-19
5
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Potential role of statins in COVID-19 Patients with
COVID-
19 infection have an increased risk of cardiovascular complications and thrombotic events. They may have a potential role as adjunctive therapy to mitigate endothelial dysfunction and dysregulated inflammation in patients with
COVID-
19 infection
6
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
Statin Treatment of COVID-19
7
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Stef Levolger
,
PhD
,
Reinoud P.H. Bokkers
,
PhD
,
Jan Wille
,
PhD
,
Rogier H.J. Kropman
,
PhD
,
Jean-Paul P.M. de Vries
,
PhD
Yıl :
2020
Arterial thrombotic complications in COVID-19 patients The coronavirus disease 2019 (
COVID-
19), a viral respiratory illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been COVID-
19. Our findings demonstrate that physicians should be vigilant for signs of thrombotic complications in both hospitalized and new
COVID-
19 patients. COVID-19
8
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
COVID-19 – A vascular disease
9
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Dergi:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
COVID-19 and cardiovascular diseases As of mid-June 2020, more than 4,40,000 fatal cases of SARS-CoV-2-related disease (
COVID-
19) have occurred worldwide. Besides its prominent expression at the level of the respiratory apparatus,
COVID-
19 is also characterized by a substantial degree of cardiovascular involvement Herein, we summarize the main
COVID-
19 features of relevance for the clinicians in the cardiovascular field. COVID-19
10
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
The renin angiotensin aldosterone system and COVID-19 The ongoing pandemic has stimulated study of the Renin Angiotensin Aldosterone System (RAAS), and how it can be manipulated to treat
COVID-
19. Studies are examining whether drugs that act on the RAAS system might be useful to treat
COVID-
19. COVID-
19 and the RAAS are closely linked both in infection and in possible post-infection inflammatory cascades. COVID-19
11
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Thrombosis Risk Assessment In The COVID-19 Era covid-19
12
Dergi Makalesi

Dergi Makalesi

Kaynak
1:
Kaynak
2:
Dergi:
Yazar(lar) :
Yıl :
2020
ST Elevations in the Era of COVID-19 Coronavirus disease 2019 (
COVID-
19) has created unique challenges in approaching patients with acute ST-segment changes. We describe two distinct cases of ST elevation on electrocardiogram occurring in patients with
COVID-
19 and review important diagnostic and management
13
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
COVID-19 infection and cardiac arrhythmias As the coronavirus 2019 (
COVID-
19) pandemic marches unrelentingly, more patients with cardiac arrhythmias are emerging due to the effects of the virus on the respiratory and cardiovascular (CV) systems and the systemic inflammation that it incurs, and also as a result of the proarrhythmic effects of
COVID -
19 pharmacotherapies and other drug interactions and the associated autonomic imbalance that enhance arrhythmogenicity. COVID-19 COVID-19 coronavirus 2019
14
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
Extensive Arterial Thrombosis in Covid-19
15
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Interventional Stroke Care in the Era of COVID-19 Patients with severe symptoms of
COVID-
19 may also present with acute neurological emergencies such as ischemic stroke. , or concurrent ischemic stroke from common stroke risk factors in a patient with
COVID-
19. Lastly, we describe an illustrative case of a patient with ischemic stroke and
COVID-
19. COVID-19
16
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Coronary thrombosis in a young male with COVID-19 COVID-
19 predominantly presents with respiratory symptoms, but other presentations are reported, including cardiac manifestations and thromboembolism. We present a healthy young gentleman with
COVID-
19 pneumonia, who developed acute ST-segment elevation myocardial infarction (STEMI) due to coronary thrombosis COVID-19
17
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Dergi:
Yazar(lar) :
Konu :
Health Policy, Pharmacology (medical), Infectious Diseases
Yıl :
2020
COVID‐19 research: an opinion piece The unprecedented global scale of
COVID‐
19 globally has triggered a race to discover interventions to reduce associated morbidity and mortality and rapid Here we summarize the evidence for antiretrovirals to treat
COVID‐
19 and, as a drug that has also been studied in HIV, hydroxychloroquine, and flag some
18
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Multisystemic Infarctions in COVID-19: Focus on the Spleen The literature suggests that
COVID-
19 provokes arterial and venous thrombotic events, although the mechanism is still unknown. More data are required to elucidate how
COVID-
19 and thrombotic disease interact and so that preventive and early diagnosis strategies can be developed covid-19
19
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Social reaction toward the 2019 novel coronavirus (COVID-19)
20
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Current data on the cardiovascular effects of COVID-19
21
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties -
19) pandemic. This review aims to discuss the pathophysiological links between MI, respiratory infections, and
Covid-
19; epidemiological data related to ACS at the time of the
Covid-
19 pandemic; and learnings that have emerged so far from several catheterization labs and coronary care units all over the world, in order Covid-19
22
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Anticoagulation practice patterns in COVID‐19: A global survey Objectives We aimed to assess current global practice and experience in management of
COVID‐
19–associated coagulopathy to identify information to guide Methods Physicians were queried about their current approach to prophylaxis, diagnosis, and treatment of VTE in patients with
COVID‐
19 using an online ‐
19. COVID‐19
23
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
Post COVID-19 Acute Myocardial Infarction Rebound
24
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Cardiovascular disease in the context of the COVID-19 pandemic Emerging evidence indicate a close relationship between coronavirus disease 2019 (
COVID-
19) and cardiovascular diseases (CVDs). As outlined in this review, cardiovascular manifestations of
COVID-
19 are complex with patients presenting with one or more of the following: myocarditis -
19 burden. covid-19
25
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Possible Mechanism and Current Recommendation of Thromboembolism in COVID-19 The coronavirus disease (
COVID-
19) has become a global pandemic with a high mortality rate. There has been emerging evidence regarding the presence of thrombosis in patients with severe
COVID-
19 infection. Prophylaxis anticoagulant was proposed for all hospitalized
COVID-
19 patients. COVID-19
26
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
COVID-19 in patients with cardiovascular diseases COVID-19
27
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Cardiovascular complications of COVID-19: evidence, misconceptions, and new opportunities
28
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Dergi:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
Higher procoagulatory potential but lower DIC score in COVID-19 ARDS patients compared to non-COVID-19 ARDS patients Background
COVID-
19 is a novel viral disease. Severe courses may present as ARDS. INR (p < 0.001) and antithrombin (p < 0.001) were higher in
COVID-
19 patients. In ExTEM®, Time-to-Twenty (TT20) was shorter in the
COVID-
19 group (p = 0.047), these patients also had higher FibTEM® MCF (p = 0.005). COVID-19 coronavirus disease 19 coronavirus disease 19